Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acute monocytic leukemia
|
22 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Adenocarcinoma Of Esophagus
|
81 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Adenomatous Polyps
|
20 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Adult Lymphoma
|
66 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
Anemia, severe
|
6 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Autism Spectrum Disorders
|
331 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1 | 2016 | 2016 | ||||||
Azoospermia
|
70 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Bladder Neoplasm
|
281 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.080 | 1.000 | 8 | 2007 | 2014 | |||||
Brain Neoplasms
|
204 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Breast Carcinoma
|
2793 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.090 | 0.889 | 9 | 2004 | 2018 | |||||
Carcinoma of bladder
|
309 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.080 | 1.000 | 8 | 2007 | 2014 | |||||
Carcinoma of lung
|
1204 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 1.000 | 14 | 2001 | 2014 | |||||
Carcinoma, Basal Cell
|
91 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1 | 2005 | 2005 | ||||||
Childhood Lymphoma
|
66 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Childhood Non-Hodgkin Lymphoma
|
39 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
Childhood Osteosarcoma
|
151 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.833 | 12 | 2012 | 2018 | |||||
Colorectal Carcinoma
|
1962 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 0.667 | 3 | 2007 | 2016 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Diffuse Large B-Cell Lymphoma
|
127 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 0.500 | 2 | 2013 | 2018 | |||||
Early infantile epileptic encephalopathy with suppression bursts
|
10 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Endometriosis
|
274 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Esophageal carcinoma
|
272 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||
Esophageal Neoplasms
|
270 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||
Experimental Organism Basal Cell Carcinoma
|
63 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1 | 2005 | 2005 |